Related Experiment Video
Updated: Jul 25, 2025

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the
Daniel L Pouliquen1, Koraljka Gall Trošelj2, Ruby John Anto3
1Université d'Angers, Inserm, CNRS, Nantes Université, CRCI2NA, F-49000 Angers, France.
Abstract:
The number of published studies on curcuminoids in cancer research, including its lead molecule curcumin and synthetic analogs, has been increasing substantially during the past two decades. Insights on the diversity of inhibitory effects they have produced on a multitude of pathways involved in carcinogenesis and tumor progression have been provided. As this wealth of data was obtained in settings of various experimental and clinical data, this review first aimed at presenting a chronology of discoveries and an update on their complex in vivo effects. Secondly, there are many interesting questions linked to their pleiotropic effects. One of them, a growing research topic, relates to their ability to modulate metabolic reprogramming. This review will also cover the use of curcuminoids as chemosensitizing molecules that can be combined with several anticancer drugs to reverse the phenomenon of multidrug resistance. Finally, current investigations in these three complementary research fields raise several important questions that will be put among the prospects for the future research related to the importance of these molecules in cancer research.
Insights
Curcuminoids show diverse anti-cancer effects by inhibiting tumor pathways and reversing drug resistance. Ongoing research explores their role in metabolic reprogramming and future therapeutic potential.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Curcuminoids, including curcumin and synthetic analogs, have seen a surge in cancer research over 20 years.
- These compounds exhibit diverse inhibitory effects on pathways crucial for carcinogenesis and tumor progression.
Purpose of the Study:
- To chronologically review discoveries and update in vivo effects of curcuminoids in cancer.
- To explore curcuminoids' role in modulating metabolic reprogramming in cancer.
- To examine curcuminoids as chemosensitizers to overcome multidrug resistance.
Main Methods:
- Literature review of experimental and clinical studies on curcuminoids in cancer research.
- Analysis of data on curcuminoids' effects on carcinogenesis, tumor progression, and metabolic pathways.
- Investigation of curcuminoids' efficacy in reversing multidrug resistance in combination therapies.
Main Results:
- Curcuminoids demonstrate a broad spectrum of inhibitory actions against multiple cancer-related pathways.
- Emerging evidence highlights their capacity to modulate cancer cell metabolic reprogramming.
- Curcuminoids show promise in resensitizing cancer cells to conventional chemotherapy, overcoming multidrug resistance.
Conclusions:
- Curcuminoids represent a significant area of cancer research with established and emerging therapeutic applications.
- Further investigation into their pleiotropic effects, particularly metabolic modulation and chemosensitization, is warranted.
- Future research should focus on translating these findings into effective clinical strategies for cancer treatment.
Related Concept Videos
Cancer Prevention
Some...
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Destabilize Microtubules

